Cameron Turtle - Chief Business Officer, Eidos Therapeutics, Inc

As of December 16, 2020


Cameron Turtle Net Worth

  • Net worth is estimated to be at least $15.06M
  • Owns at least 50,621 units of Eidos Therapeutics, Inc stock
  • Sold an estimated value of $8.21M in the last year at Eidos Therapeutics, Inc

Cameron Turtle Compensation at Eidos Therapeutics, Inc in 2020

  • Earned a $400,000 salary and a $210 bonus
  • Rewarded $3,940,081 in stock value and options
  • Received a total compensation of $4,561,482

Cameron Turtle Trading

  • Largest purchase of shares was 26,294 units , worth over $363.99K on December 16, 2020
  • Largest sale of shares was 26,294 units , worth over $2.94M on December 16, 2020
  • In total has made about 13 transactions over a year
  • Usually trades in November, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Cameron Turtle Mailing Address

  • Mailing address is C/o Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2550 San Francisco CA 94104 CA

Eidos Therapeutics, Inc Insider Trading

  • The most recent transaction was 14,428,836 units bought on January 26, 2021 by Bridgebio Pharma Inc worth over $0
  • In the last 3 years, insiders at Eidos Therapeutics, Inc sold an estimated value of $34.74M and bought an estimated value of $352.62M
  • The most active traders are Jonathan Fox, See Remarks,  Cameron Turtle, Chief Business Officer,  and Christine Siu, CFO and Secretary
  • Insider trading is most common in June, with the busiest year in 2019

Eidos Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1